×

CellRapeutics™ Leukopak from Allergy Donor (XS-0426-XU225)

Online Inquiry  Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Collected from donors with documented hypersensitivities, this Leukopak is enriched with immune cells primed for IgE-mediated responses. The product contains high frequencies of allergen-specific Th2 cells, basophils, and eosinophils. This large-scale cellular collection is optimized for high-throughput screening of anti-allergic compounds, the study of mast cell-basophil activation, and the characterization of the Th2-driven cytokine milieu.

Specific Inquiry

  • Size:
  Add to Cart

Donor Information

  • Product Name
  • CellRapeutics™ Leukopak from Allergy Donor
  • Cat. No.
  • XS-0426-XU225
  • Donor Age
  • Young Adult
  • Donor Health
  • Leukocytes reflect a strong Th2-polarized immune bias. The cell population contains expanded allergen-specific memory cells and potentially elevated circulating granulocyte precursors associated with Type I hypersensitivity.
  • Ethnicity
  • Diverse backgrounds available.
  • Anticoagulant
  • Heparin or Acid Citrate Dextrose, optimized to prevent basophil activation and maintain the stability of allergen-specific IgE-bearing cells.
  • Additional Donor Information
  • Each lot features a Leukopak from donors with documented environmental or food allergies. Profiles include specific IgE levels and skin prick test results to support Th2-mediated response research.
  • Clinical Profile
  • Specific allergen triggers, total IgE levels, and history of anaphylaxis or immunotherapy.

Additional Information

  • Medication History
  • Available upon request. Includes history of H1/H2 antihistamines, leukotriene receptor antagonists, and allergen-specific immunotherapy history.
  • Formulation
  • Cryopreserved or Fresh options available.
  • Cell Purity
  • >90%
  • Cell Viability
  • >90%
  • Mycoplasma Testing
  • Negative
  • Sterility Testing
  • Negative
  • Genetic Stability Testing
  • The donor cells maintain their native genetic profile, exhibiting no karyotypic abnormalities or chromosomal instabilities typically associated with prolonged ex vivo expansion.
  • Application
  • Drug Discovery, Immuno-oncology Research
  • Research Use Only
  • RUO
  • Quality Control
  • Each product batch is strictly validated for high cellular viability, specific immune cell counts, and pathogen-free safety, ensuring consistent clinical phenotypes and ethical compliance for advanced immunological research.
  • Storage
  • Store fresh Leukopaks at 2°C to 8°C for immediate use, cryopreserved samples must be kept in liquid nitrogen vapor phase below -150°C.
  • Shiping
  • Dry Ice
  • Handling Notes
  • Process fresh cells within 48 hours or perform rapid thawing of cryovials in a 37°C water bath followed by gradual dilution to maximize recovery.
  • Warnings
  • Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.
  • Size
  • Full Bag, Half Bag
  • Keywords
  • CellRapeutics™ Leukopak from Allergy Donor, Leukopak, Allergy

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ Leukopak from Allergy Donor (XS-0426-XU225). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

Key Updates
Newsletter. (Creative Biolabs Authorized) NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution. (Creative Biolabs Authorized) NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
Novel Solution. (Creative Biolabs Authorized) NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
New Technology. (Creative Biolabs Authorized) NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.